314e Boosts Healthcare Document Processing Efficiency by Up to 3X with Dexit
YARDLEY, Pa., Feb. 12, 2025 /PRNewswire/ -- 314e Corporation, a leading provider of healthcare IT solutions, introduces Dexit—an AI-native Intelligent Document...
Month: February 2025
Emmes Group advances data security as ISMS certified ISO compliant
Gold-standard accreditation underscores Emmes Group's commitment to secure and data-rich trials for biotech and pharma partners ROCKVILLE, Md., Feb. 12,...
New CAQH Index Reveals $20B Savings Opportunity to Cut Waste, Reduce Costs, and Improve Patient Access
The latest CAQH Index highlights urgent need for automation to eliminate inefficiencies, ease provider burdens, and accelerate access to care...
FAIR Health Launches Alzheimer’s Disease Shared Decision-Making Tool and Supplementary Resources
Cost Information, Printable Checklists and More Are Offered for Free to Help Older Adults and Family Caregivers Make Choices About...
Medicomp Systems Announces Support for USCDI v3, v4 and v5 Along with SDOH Accelerator Tools
New Quippe® Compliance Tools Advance Data Interoperability and Drive Personalized Care CHANTILLY, Va., Feb. 12, 2025 /PRNewswire/ -- Medicomp Systems,...
TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients’ Access to Life-Changing Medicines
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. CAMBRIDGE, Mass., Feb. 12, 2025 /PRNewswire/...
Terrain Biosciences emerges from stealth to enable faster therapeutics and vaccine development with better RNA
- Founded by Professors Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu leveraging novel AI models and technologies for designing, building,...
Dalan Animal Health Unlocks the Power of Innate Immunity for a New Era in Disease Prevention
ATHENS, Ga., Feb. 12, 2025 /PRNewswire/ -- Dalan Animal Health, a global leader in bioscience innovation, today announced a major breakthrough...
Clearsense Announces Strategic Rebrand and Relocation of Headquarters to Nashville
New market position highlights Clearsense as a leading healthcare data enablement platform, showcasing the transformative value of its solutions NASHVILLE,...
Nanomosaic Announced Release of Joint White Paper with BMS Investigating Nanoneedle Technology to Improve AAV Manufacturing Process and Product Quality
WALTHAM, Mass., Feb. 12, 2025 /PRNewswire/ -- Nanomosaic, a leader in multiplex, multi-omic marker analysis, today announced the publication of a scientific white paper detailing a study...
TE Connectivity to acquire Richards Manufacturing to expand position in fast-growing energy market
GALWAY, Ireland, Feb. 12, 2025 /PRNewswire/ -- TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, has entered...
CorVista Health Announces Leadership Succession, Appointing Adrian Lam as President and CEO
Adrian Lam appointed President and CEO of CorVista HealthDon Crawford to retire following a distinguished 42-year career in MedTechTim Attebery...
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million...
Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Completed Phase 2 enrollment with randomization of 51 subjects into treatment and control armsPhase 1/2 study (N=60) demonstrated favorable safety...
Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs
Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with...
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell engagersXilio to...
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses...
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex...
BioCryst Launches ORLADEYO® (berotralstat) in Portugal
RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Infarmed in Portugal...
Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food...